ORIGINAL RESEARCH
Published on 26 Sep 2025
Time and cost burden associated with docetaxel in patients with metastatic castration-sensitive prostate cancer initiating an androgen receptor pathway inhibitor-based regimen
doi 10.3389/fonc.2025.1650378
- 403 views